November 2018 Briefing – Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for November 2018. This roundup includes the latest...
Higher Cardiovascular Risk Seen With Psoriatic Arthritis
Risk seems to be increased especially in patients with a high inflammatory burden, late-onset psoriasis
Four Principles Underlie Patient and Family Partnership in Care
Patients, families should be treated with dignity and respect, be actively engaged in care
FDA to Update Medical Device Approvals Process
Revised process will ensure new medical devices meet safety and effectiveness standards
ACA Coverage Substantial, but Did Not Impact Labor Markets
Coverage gains did not negatively impact employment levels, hours worked, earnings
Novel Scoring System Can Up Access to Biologics in Psoriasis
DLQI-R allows more patients to achieve threshold for becoming candidates for biologic treatment
CDC: 8.8 Percent Uninsured in U.S. in First Half of 2018
12.5 percent of adults aged 18-64 years and 4.4 percent of children aged 0-17 years uninsured
Name-Brand Medications Driving Spike in U.S. Drug Spending
Greatest costs for Humira, Remicade, Enbrel, Novolog, and Neulasta
Patient Experiences Shed Light on Diagnostic Errors
Problems related to patient-physician interactions contribute to diagnostic errors
AMA to Collect Data on Suicide Among Doctors-in-Training
Administration hopes to identify the systemic factors that contribute to this problem
